Minimally invasive detection of early-stage opisthorchiasis-associated cholangiocarcinoma using label-free surface-enhanced Raman spectroscopy (SERS) of hamster serum
Open Access
- 27 October 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (10) , e0334916
Abstract
Background: Cholangiocarcinoma (CCA) is a deadly cancer often detected late. Current diagnostic methods, such as ultrasound and invasive biopsies, have limitations; there is a critical need for a rapid, minimally invasive and effective strategy for the early diagnosis and staging of CCA. Methods: We aimed to address this need using serum samples and label-free surface-enhanced Raman spectroscopy (SERS) combined with machine learning. CCA development was induced in hamsters using a combination of Opisthorchis viverrini infection and administration of N -nitrosodimethylamine, with induction time courses spanning 1–5 month(s). Normal and pathological stages (inflammation, precancerous lesion, and CCA) were assigned based on histopathological features, as well as the expression of cytokeratin 19 and alpha-fetoprotein. Raman spectra were subjected to dimensionality reduction using principal component analysis, and diagnostic clusters were acquired using partial least-squares discriminant analysis. Results: Histopathological analysis confirmed a clear path towards CCA, initiated by marked inflammation, progressing to include significant cholangiofibrosis and cholangiofibroma in the precancerous stage, and culminating in definitive CCA tumor development. The integration of SERS and machine learning achieved a diagnostic sensitivity of 93%, specificity of 95%, and accuracy of ≥ 67% for precancerous lesions and CCA, with an area under the receiver operating characteristic curve exceeding 0.67. Conclusions: Our findings demonstrate that this cost-effective, label-free SERS approach can accurately detect precancerous and cancerous stages of cholangiocarcinoma in a hamster model, highlighting its strong potential for future development as a community-based screening tool.Keywords
This publication has 42 references indexed in Scilit:
- Surface-enhanced Raman spectroscopy of the filtrate portions of the blood serum samples of breast cancer patients obtained by using 30 kDa filtration deviceSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2024
- Determination of latent tuberculosis infection from plasma samples via label-free SERS sensors and machine learningBiosensors and Bioelectronics, 2024
- Application of surface-enhanced Raman spectroscopy to human serum for diagnosing liver cancerSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2023
- Raman spectroscopic study of cervical precancerous lesions and cervical cancerLasers in Medical Science, 2021
- Applications of Raman spectroscopy in cancer diagnosisCancer and Metastasis Reviews, 2018
- Screening for Hepatocellular Carcinoma and Cholangiocarcinoma: Can Biomarkers Replace Imaging?Current Hepatology Reports, 2015
- Biomarkers in cholangiocarcinomaClinical Liver Disease, 2014
- Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patientsJournal of Hepato-Biliary-Pancreatic Sciences, 2014
- Molecular imaging of live cells by Raman microscopyCurrent Opinion in Chemical Biology, 2013
- Involvement of MMP‐9 in peribiliary fibrosis and cholangiocarcinogenesis via Rac1‐dependent DNA damage in a hamster modelInternational Journal of Cancer, 2010